Clinical trials
Phase 2 Chronic Urticaria trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 9 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 8 |
| Not yet recruiting | 6 |
| Recruiting | 6 |
| Unknown status | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Genentech, Inc. | 3 |
| Allakos Inc. | 2 |
| ARS Pharmaceuticals, Inc. | 1 |
| Ahuva D Cices | 1 |
| Akeso | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Barnsley Hospital | 1 |
| Blueprint Medicines Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chronic Urticaria | 51 |
| Urticaria | 12 |
| Pruritus | 6 |
| Chronic Inducible Urticaria | 3 |
| Angioedema | 2 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Cold Urticaria | 2 |
| Hidradenitis | 1 |
| Hidradenitis Suppurativa | 1 |
| Lichen Planus | 1 |
Trials
Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.